Natural Capsules

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE936B01015
  • NSEID: NATCAPSUQ
  • BSEID: 524654
INR
161.90
9.8 (6.44%)
BSENSE

Jun 18

BSE+NSE Vol: 50.89 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 349207,
    "name": "Natural Capsules",
    "stock_name": "Natural Capsules",
    "full_name": "Natural Capsules Ltd",
    "name_url": "stocks-analysis/natural-capsules",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "161.90",
    "chg": 9.8,
    "chgp": "6.44%",
    "dir": 1,
    "prev_price": "152.10",
    "mcapval": "159.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524654,
    "symbol": "NATCAPSUQ",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE936B01015",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "50.89 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/natural-capsules-349207-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 152,
    "sid": "349207",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/natural-capsules-349207"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "03-Jun-2026",
      "details": "Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of transcript of Conference Call held on Tuesday June 02 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "02-Jun-2026",
      "details": "Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Audio recording of Conference Call held on Tuesday June 02 2026 is available on the website of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Corrigendum To The Intimation Under Regulation 30(9) Of SEBI (LODR) Regulations 2015 Dated May 27 2026.",
      "datetime": "01-Jun-2026",
      "details": "This has reference to our intimation under regulation 30(9) of SEBI (LODR) Regulation 2015 submitted to the Stock Exchange on May 27 2026 regarding the outcome of the Board Meeting of Material Unlisted Subsidiary (i.e. Natural Biogenex Private Limited) dealing the approval of the Right Issue. We wish to inform the exchange that due to a Typographical /Clerical error the total number of Equity Shares for the right issue was in inadvertently mentioned as 1111200 instead of 1111205.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Natural Capsules Ltd has declared <strong>10%</strong> dividend, ex-date: 20 Jul 23",
          "dt": "2023-07-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Natural Capsules Ltd has announced <strong>1:2</strong> rights issue, ex-date: 11 Nov 21",
          "dt": "2021-11-11",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

03-Jun-2026 | Source : BSE

Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of transcript of Conference Call held on Tuesday June 02 2026.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

02-Jun-2026 | Source : BSE

Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Audio recording of Conference Call held on Tuesday June 02 2026 is available on the website of the Company.

Corrigendum To The Intimation Under Regulation 30(9) Of SEBI (LODR) Regulations 2015 Dated May 27 2026.

01-Jun-2026 | Source : BSE

This has reference to our intimation under regulation 30(9) of SEBI (LODR) Regulation 2015 submitted to the Stock Exchange on May 27 2026 regarding the outcome of the Board Meeting of Material Unlisted Subsidiary (i.e. Natural Biogenex Private Limited) dealing the approval of the Right Issue. We wish to inform the exchange that due to a Typographical /Clerical error the total number of Equity Shares for the right issue was in inadvertently mentioned as 1111200 instead of 1111205.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Natural Capsules Ltd has declared 10% dividend, ex-date: 20 Jul 23

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Natural Capsules Ltd has announced 1:2 rights issue, ex-date: 11 Nov 21